Search »
- Use quotation marks (e.g., "RSR Manual") to search for exact phrases.
- You must be logged in to search for people in the Ryan White/TargetHIV community.
Content type
Topic Areas
Source
Publication Date
-
News Article updated on 10/01/2021
-
Four Things to Know About Open Enrollment 2022
-
Development of an HIV Data Management System with User Input
Informal peer-to-peer discussion on Colorado's RWHAP data management system, developed in partnership with other agencies.Resource updated 04/06/2023
-
RWHAP-HIV Surveillance Data Matching and Sharing Process
Outline of a possible approach to matching and sharing data across the RWHAP and HIV surveillance programs at the local level.Resource updated 09/14/2023
-
DISQ Office Hours
Sessions for RWHAP agencies to talk with their peers about technical challenges and solutions. IDENTIFYING CLIENTS WITH HIV FOR REPORTING AND CARE MANAGEMENT PURPOSESResource updated 07/02/2024
-
RWHAP Data Infrastructure In Focus: Data Matching & Sharing with HIV Surveillance
Overview of the benefits and best practices in matching and sharing data across HRSA and CDC systems.Resource updated 09/19/2023
-
Office Hours: A New TA Platform for Data Support
From the DISQ Listserv - Dear RWHAP community
News Article updated on 09/10/2021 -
Hybrid Format for Ryan White 2022
Next year’s Ryan White Conference will adopt an in-person/virtual format, while the Clinica
News Article updated on 10/15/2021 -
Rapid ART: An Essential Strategy for Ending the HIV Epidemic
What HIV care providers can do to create a rapid ART program to get HIV clients on treatment the same day as a diagnosis.Resource updated 09/19/2023
-
Four things to know about Open Enrollment 2022
To help you stay on top of the latest updates, the ACE TA Center has compiled this list of four “things to know” about helping consumers navigate this year’s Marketplace Open Enrollment.Blog updated 11/09/2021
-
Rapid ART Playbook Outlines Steps to Implementation
Guide on implementing rapid ART the administration of antiretroviral therapy (ART) as quickly as possible and ideally on the same day as an HIV diagnosis/clinic visit.Blog updated 03/03/2022
-
TAP-in EHE Webinar Series
Recordings of the TAP-in webinars on topics critical to the Ending the HIV Epidemic Initiative.Resource updated 05/23/2023
-
Central Eligibility for RWHAP Enrollment
Informal peer-to-peer discussion on the Maricopa County integrated eligibility process.Resource updated 09/19/2023
-
Use of Social Media and Mobile Technology as Essential Tools for EHE
Strategies to engage hard-to-reach youth and young adults through use of social media and related technologies.Resource updated 03/15/2023
-
Marketplace Subsidies and Unemployment Compensation
New Marketplace subsidies are available for people who received unemployment compensation in 2021.Blog updated 12/15/2021
-
Ending the HIV Epidemic through Innovations in Rapid ART
Review of innovative Rapid ART strategies in diverse settings.Resource updated 03/15/2023
-
Medical Monitoring Project 2019-2020 Data on HIV Care Access and Health Outcomes
In the U.S., almost all people with HIV have some type of health insurance coverage (pub
News Article updated on 08/09/2021 -
Building Partnerships for Data Sharing to Support EHE Plans
Review of building data partnerships with agencies that manage and control access to data, which can support planning and evaluation of EHE activities.Resource updated 04/07/2023
-
New Investigational ART Drugs and Strategies
Review of investigational drugs in phase III trials (as of 2021: Islatravir, Lenacapravir, GSK 3640254/aka GSK “254) and how these investigational agents might be used in treatment in the future. Also, review of long-acting injectables.Resource (Conference Presentation) updated 09/14/2023
-
Managing Polypharmacy and Drug-Drug Interactions
Review of common mechanisms for drug interactions with contemporary ART; therapeutic classes of drugs with high interaction potential with ART; distinctions between oral vs intramuscular cabotegravir/rilpivirin interactions; and comparison of the clinical pharmacology and drug interaction potential of tenofovir alafenamide vs tenofovir disoproxilfumarate.Resource (Conference Presentation) updated 09/14/2023